Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Recombinant multiantigen AIDS vaccine enters second phase I trial

July 1, 1997

No Comments

Three-drug therapy shown effective against AIDS

June 24, 1997

No Comments

LMW inhibitor of Tat-TAR interaction and HIV replication prepared at Novartis

June 18, 1997

No Comments

FDA advisory on AIDS drugs

June 17, 1997

No Comments

Second-generation NNRTI under development by Hoechst/Bayer

June 16, 1997

No Comments

Paracelsian cancels launch of AndroVir

June 12, 1997

No Comments

Carbovir not associated with mitochondrial toxicity in intact cells

June 12, 1997

No Comments

Nevirapine for prophylaxis of HIV infection

June 11, 1997

No Comments

Introduction of Rescriptor in late June

June 10, 1997

No Comments

Anti-HIV vaccines reported by Duke University

June 6, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

HIV/AIDS
RSS

Recombinant multiantigen AIDS vaccine enters second phase I trial

Three-drug therapy shown effective against AIDS

LMW inhibitor of Tat-TAR interaction and HIV replication prepared at Novartis

FDA advisory on AIDS drugs

Second-generation NNRTI under development by Hoechst/Bayer

Paracelsian cancels launch of AndroVir

Carbovir not associated with mitochondrial toxicity in intact cells

Nevirapine for prophylaxis of HIV infection

Introduction of Rescriptor in late June

Anti-HIV vaccines reported by Duke University

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

HIV/AIDS RSS

HIV/AIDS
RSS